Lunai Bioworks Inc. (LNAI)
NASDAQ
Closed
Oct 28, 2026
Day's Range
0.202052 wk Range
0.2020Profile - LNAI - Lunai Bioworks Inc.
Profile
Mic Code
XNCM
Sector
Healthcare
Industry
Biotechnology
Employees
12
Lunai Bioworks Inc. is a pre-clinical biotechnology company focused on developing medicines, diagnostics, and biodefense solutions. The company works across cancer, infectious disease, and precision medicine through genetically modified cell and immune-therapy platforms, including allogeneic dendritic cell vaccine programs for solid tumors such as pancreatic and breast cancers. Its business also includes AI-enabled diagnostics and multi-omics analytics designed to support early cancer detection and recurrence monitoring by identifying individual biomarkers, including in asymptomatic patients. Through its operating segments, Lunai Bioworks combines computational biology, experimental biology, and data-driven platforms to advance therapeutic discovery and improve clinical decision-making. The company is headquartered in Los Angeles, California, and serves healthcare-related markets in the United States and the Netherlands.
Profile Details
Type
Common Stock
Address
3400 Cottage Way
City
Sacramento
State
CA
Zip
95825
Country
United States
Phone
(424) 222-9301
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
